BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26324236)

  • 21. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.
    Garofalo M; Jeon YJ; Nuovo GJ; Middleton J; Secchiero P; Joshi P; Alder H; Nazaryan N; Di Leva G; Romano G; Crawford M; Nana-Sinkam P; Croce CM
    PLoS One; 2013; 8(6):e67581. PubMed ID: 23805317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.
    Wu D; Pan H; Zhou Y; Zhang Z; Qu P; Zhou J; Wang W
    Mol Med Rep; 2015 Nov; 12(5):7059-64. PubMed ID: 26323722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.
    Sun JY; Huang Y; Li JP; Zhang X; Wang L; Meng YL; Yan B; Bian YQ; Zhao J; Wang WZ; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2012 Apr; 420(4):787-92. PubMed ID: 22459450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
    Öner MG; Rokavec M; Kaller M; Bouznad N; Horst D; Kirchner T; Hermeking H
    Gastroenterology; 2018 Dec; 155(6):1868-1882. PubMed ID: 30099074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
    Ouyang Y; Gao P; Zhu B; Chen X; Lin F; Wang X; Wei J; Zhang H
    Mol Med Rep; 2015 Feb; 11(2):1435-41. PubMed ID: 25351256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C.
    Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H
    Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
    Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.
    Tian X; Wei Z; Wang J; Liu P; Qin Y; Zhong M
    Oncol Rep; 2015 Aug; 34(2):707-14. PubMed ID: 26058485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).
    Joglekar-Javadekar M; Van Laere S; Bourne M; Moalwi M; Finetti P; Vermeulen PB; Birnbaum D; Dirix LY; Ueno N; Carter M; Rains J; Ramachandran A; Bertucci F; van Golen KL
    Neoplasia; 2017 Jul; 19(7):564-573. PubMed ID: 28609680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability.
    Wang TH; Chang JL; Ho JY; Wu HC; Chen TC
    FEBS J; 2012 Jan; 279(2):251-63. PubMed ID: 22074469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.
    Li W; Jin X; Deng X; Zhang G; Zhang B; Ma L
    Biochem Biophys Res Commun; 2014 Jun; 449(2):235-40. PubMed ID: 24845562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chloroform fraction of Scutellaria barbata D. Don inhibits the growth of colorectal cancer cells by activating miR‑34a.
    Zhang L; Fang Y; Feng JY; Cai QY; Wei LH; Lin S; Peng J
    Oncol Rep; 2017 Jun; 37(6):3695-3701. PubMed ID: 28498458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.